Core Viewpoint - The S&P 500's dividend yield is nearing record lows at approximately 1.2%, yet there are several high-quality companies offering dividends with yields of 5% or more, providing opportunities for passive income seekers [1]. Group 1: High-Yield Dividend Stocks - Realty Income has a dividend yield above 5.5%, supported by a diversified real estate portfolio and a strong financial profile, with a record of 661 consecutive monthly dividends and 131 increases since its IPO in 1994 [4][6]. - Clearway Energy's dividend yield is just below 5.5%, with stable cash flow generated from long-term power purchase agreements, and plans to grow cash available for dividends from $2.08 per share this year to over $2.50 by 2027 [7][8]. - Healthpeak Properties offers a yield over 6.5%, with a high-quality portfolio of healthcare properties and a strong financial profile, including $500 million to $1 billion in capacity for additional investments [9][10]. - Oneok's dividend yield exceeds 5%, with 90% of earnings from fee-based sources, aiming for a 3% to 4% annual increase in dividends supported by acquisition synergies and expansion projects [11][12]. - Verizon has a dividend yield approaching 6.5%, generating $19.8 billion in free cash flow last year, which comfortably covered its $11.2 billion in dividend payments, allowing for continued dividend increases [13][14]. Group 2: Investment Rationale - Realty Income, Clearway Energy, Healthpeak Properties, Oneok, and Verizon all provide dividends above 5%, backed by recurring cash flow and strong balance sheets, making them solid choices for passive income investments [15].

Group 1 - The Fidelity MSCI Health Care Index ETF (NYSEARCA: FHLC) is a passive ETF that invests in the healthcare industry and its performance aligns with industry peers [1] - The article emphasizes the importance of examining small details when analyzing the ETF's performance [1] Group 2 - The author has a background in finance, with expertise in corporate finance, M&A, and investment analysis, particularly in real estate, renewable energy, and equity markets [1] - The author aims to share insights and analysis on companies of interest to a global audience, promoting informed decision-making [1]

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the Centene class act ...

Key Takeaways OPRX Q1 revenues rose 11% YoY to $21.9M with $1.5M adjusted EBITDA and raised FY25 guidance. OPRX's DAAP and subscription model drive margin gains, with 80% of FY25 revenues under contract. OPRX cut OpEx by $5M and targets Rule of 40 status, but gross margin dipped on managed services mix.OptimizeRx (OPRX) is making a bold shift toward AI-driven, workflow-integrated solutions, signaling a strategic evolution that could redefine its role in digital pharma communications. On its first-quarter ...

TOLEDO, Ohio, July 11, 2025 /PRNewswire/ -- Welltower® Inc. (NYSE: WELL) today announced it will release second quarter 2025 financial results after the close of trading on the New York Stock Exchange on Monday, July 28, 2025. The Company will host a conference call and webcast on Tuesday, July 29, 2025, at 9:00 a.m. ET to discuss these results. The Company's earnings release will be available in the Investor Relations section of the Company's website.Investors and other interested parties may access the co ...

Core Viewpoint - The healthcare industry, with annual expenditures of $4.9 trillion in the U.S., presents significant opportunities for dividend investing through quality companies that exhibit consistent growth and strong financial health [1][4]. Group 1: Medtronic - Medtronic is a leading healthcare technology company with a focus on cardiovascular, diabetes, medical-surgical, and neuroscience products, conducting over 190 active clinical trials and holding 43,000 active patents [4][6]. - The company has a history of 47 consecutive annual dividend increases and is on track to become a Dividend King upon its 50th increase, currently yielding 3.2% [5][6]. - Analysts project Medtronic's earnings to grow by 6% to 7% annually over the next three to five years, supported by strategic moves such as spinning off its diabetes business [6][5]. Group 2: AbbVie - AbbVie is a pharmaceutical giant known for its successful drug Humira and has effectively transitioned post-patent expiration, with new drugs Rinvoq and Skyrizi showing promise [8][10]. - The company has achieved 53 consecutive dividend increases since its 2013 spin-off from Abbott Laboratories, currently yielding 3.5% and averaging a 7.7% increase in dividends over the past five years [9][10]. - Analysts expect AbbVie to generate nearly $60 billion in revenue this year, with long-term earnings growth projected at 13% annually, highlighting its strong product development capabilities [10][9]. Group 3: Johnson & Johnson - Johnson & Johnson is a highly recognized healthcare company that spun off its consumer segment in 2023 to focus on pharmaceuticals and medical devices [11][12]. - The company boasts an AAA credit rating and has maintained 62 consecutive years of dividend payments and increases [12][13]. - Analysts forecast earnings growth of just over 6% annually for the next three to five years, with a dividend payout ratio of only 50% of estimated earnings for 2025, starting with a yield of 3.3% [13][12].

Market Overview - Major indices in China opened higher, with the Shanghai Composite Index up 0.05%, Shenzhen Component Index up 0.06%, and ChiNext Index up 0.02% [1] - The Shanghai Composite Index reached 3,511.37 points, while the Shenzhen Component Index was at 10,637.45 points [2] US Market Performance - US stock indices collectively rose, with the Dow Jones up 0.43% at 44,650.64 points, S&P 500 up 0.27% at 6,280.46 points, and Nasdaq up 0.09% at 20,630.66 points, marking new highs [3] - Chinese concept stocks saw a general increase, with notable gains in companies like ZTO Express (up 9.21%) and Beike (up 6.52%) [3] Industry Insights - Huatai Securities remains optimistic about the upward trend in copper prices, viewing recent price corrections as potential buying opportunities, especially in light of upcoming tariffs on copper [4] - CICC suggests investors focus on performance and valuation recovery opportunities in the electric grid and industrial control sectors in the second half of the year, highlighting sustained investment growth in the electric grid [5] - CITIC Securities indicates that despite high valuations in US stocks, there may be opportunities for investment, particularly in technology and telecommunications sectors, as the market adjusts to tariff impacts [6] Technological Developments - Huatai Securities predicts a significant turning point in the development of multimodal large models and applications, driven by advancements in technology and commercial progress [7] - The firm emphasizes the importance of recognizing the mainstream adoption of native multimodal architectures and the need to focus on global advancements in AI commercialization [8]

Identity Verification & Security - Clear emphasizes the increasing importance of trusted and witnessed identity in an AI-driven world with synthetic identities [1] - Clear partners with companies like Greenhouse to ensure identity integrity of applicants, addressing concerns about workforce infiltration [1] - Clear's technology is used for workforce identification, as seen in the partnership with T-Mobile, enhancing workforce security and asset protection [3][4] - Clear partners with Octa to provide a more powerful authentication and access product for the workforce [6] - Clear believes that ubiquitous identity verification is essential for companies dealing with sensitive information or IP [7] Technology & AI Integration - Clear utilizes AI in various workstreams, including legal, finance, HR, and operations [1] - Clear's technology aims to drive efficiency and automation in identity verification processes [5] Market Opportunity & Expansion - The addressable market for trusted identity solutions is massive, both in the US and globally [2] - Clear is expanding into healthcare, partnering with Epic to provide a seamless way for patients to access their data [14] Travel Industry - Clear sees strong secular demand for travel and aims to improve the day of travel experience for consumers [11] - Clear announced a concierge product in its mobile app to assist travelers at the airport [13] Privacy & Trust - Clear prioritizes being a trusted brand with privacy policies that give consumers control over their data [9] - Clear addresses concerns about facial scanning by focusing on transparency and user control over data [9] Public-Private Partnerships - The company acknowledges the Trump administration's support for public-private partnerships, which has benefited Clear's growth [15]

NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. (NYSE: HIMS). Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/hims-hers-health-inc-loss-submission-form/?id=156058&from=3 CLASS PERIOD: A ...

The headquarters of Epic, the leading provider of electronic medical records in the U.S., looks nothing like a typical tech campus. It features treehouses, yellow brick roads and sheep fitted with AirTags. (Corrects typo in earlier video, now deleted.) https://t.co/yMzVBxI1eq https://t.co/XL5t2aBqO8 ...